Resmed (RSMDF) Net Cash Flow (2009 - 2026)

Resmed (RSMDF) has reported Net Cash Flow for 18 consecutive years, with -$192.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 179.69% year-over-year to -$192.2 million; the trailing twelve-month figure through Jun 2026 stood at $253.6 million (down 73.17% YoY), and the FY2026 full-year result was $253.6 million, down 73.17% from the prior year.
• Net Cash Flow slipped to -$192.2 million in Q2 2026 per RSMDF's latest filing, from $240.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $402.8 million in Q1 2025 and bottomed at -$192.2 million in Q2 2026.
• Historically, Net Cash Flow has averaged $69.8 million across 5 years, with a median of $31.7 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow tumbled 454.16% in 2023, then soared 74796.27% in 2025.
• Over 5 years, Net Cash Flow stood at $35.1 million in 2022, then plunged by 120.69% to -$7.3 million in 2023, then soared by 1811.28% to $124.4 million in 2024, then slumped by 75.52% to $30.5 million in 2025, then sank by 731.06% to -$192.2 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$192.2 million, $240.9 million, and $30.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.